Genmab A/S (GMAB) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Genmab A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
126.06
Weak
WeakModerateStrong
P/B Ratio
21.59
Weak
WeakModerateStrong
Earnings Yield
0.79%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
17.13%
Strong
WeakModerateStrong
Operating Margin
33.60%
Strong
WeakModerateStrong
Net Profit Margin
25.89%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-82.70%
Weak
WeakModerateStrong
Net Income Growth
-87.71%
Weak
WeakModerateStrong
EPS Growth
-87.25%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
2.02
Strong
WeakModerateStrong
Quick Ratio
2.01
Strong
WeakModerateStrong
Asset Turnover
0.30x
Weak
WeakModerateStrong
Inventory Turnover
17.85x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.95%
Weak
WeakModerateStrong
EV / Free Cash Flow
108.89x
Weak
WeakModerateStrong
Net Debt / EBITDA
2.80x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.963
Strong
WeakModerateStrong
Return on Invested Capital
8.86%
Weak
WeakModerateStrong
Cash Conversion Cycle
-1085.20 days
Strong
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GMAB.
View Financial Statements